| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
12.25 |
% |
10.6019/CHEMBL4513141 |
| Bacillus anthracis |
Anthrax lethal factor |
Potency |
10000.0 |
nM |
None |
| Bacillus anthracis |
Anthrax lethal factor |
Potency |
15848.9 |
nM |
None |
| Bacillus anthracis |
Anthrax lethal factor |
Potency |
19952.6 |
nM |
None |
| Bacillus subtilis (strain 168) |
DNA polymerase III |
Potency |
29934.9 |
nM |
None |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Inhibition |
2.59 |
% |
10.6019/CHEMBL4513141 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
5.59 |
% |
10.6019/CHEMBL4513141 |
| Equus caballus |
Ferritin light chain |
Potency |
10000.0 |
nM |
None |
| Equus caballus |
Ferritin light chain |
Potency |
12589.3 |
nM |
None |
| Equus caballus |
Ferritin light chain |
Potency |
35481.3 |
nM |
None |
| Escherichia coli |
Escherichia coli |
Inhibition |
7.34 |
% |
10.6019/CHEMBL4513141 |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
786-0 |
GI50 |
31915.38 |
nM |
None |
| Homo sapiens |
A549 |
GI50 |
38459.18 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
ACHN |
GI50 |
33884.42 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
24729.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
37650.5 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
3500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Androgen Receptor |
Inhibition |
82.0 |
% |
10.1073/pnas.0708036104 |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
231.0 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
461.1 |
nM |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
6400.0 |
nM |
10.1016/j.ejmech.2022.114346 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
4000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bloom syndrome protein |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Breast cancer type 1 susceptibility protein |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Breast cancer type 1 susceptibility protein |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Bromodomain adjacent to zinc finger domain protein 2B |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
CAKI-1 |
GI50 |
45498.81 |
nM |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
42.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Caspase-1 |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Caspase-7 |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CCRF-CEM |
GI50 |
19998.62 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
COLO 205 |
GI50 |
41879.36 |
nM |
None |
| Homo sapiens |
COR-L23 |
Activity |
100.0 |
% |
10.1021/jm101493z |
| Homo sapiens |
COR-L23 |
Inhibition |
nan |
% |
10.1021/jm101493z |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
1258.93 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
5011.87 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
DNA dC->dU-editing enzyme APOBEC-3F |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
2909.1 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
DU-145 |
GI50 |
48752.85 |
nM |
None |
| Homo sapiens |
EKVX |
GI50 |
25585.86 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
16.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
IC50 |
8.1 |
nM |
10.1038/s41598-019-48829-3 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
IC50 |
144.8 |
nM |
10.1021/jm070311l |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
Inhibition |
86.7 |
% |
10.1021/jm070311l |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
Ki |
8.18 |
nM |
10.1021/jm070311l |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
Ki |
8.79 |
nM |
10.1016/j.bmcl.2004.02.016 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Eyes absent homolog 2 |
Potency |
125892.5 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
2059.6 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
2310.9 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
5956.9 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
6993.4 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
9441.1 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
11582.1 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
25929.0 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
GTP-binding nuclear protein Ran/Importin subunit beta-1/Snurportin-1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Guanine nucleotide-binding protein G(i) subunit alpha-1/Regulator of G-protein signaling 12 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
H4 |
Activity |
30.25 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
32.22 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
32.54 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
79.08 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
79.22 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
81.07 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
82.64 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
158.96 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
170.2 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
199.02 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
H4 |
Activity |
213.63 |
% |
10.1073/pnas.0709695104 |
| Homo sapiens |
HCC 2998 |
GI50 |
16255.49 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
40271.7 |
nM |
None |
| Homo sapiens |
HCT-15 |
GI50 |
31405.09 |
nM |
None |
| Homo sapiens |
Heat shock protein HSP90 |
IC50 |
21068.2 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
517.1 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
25929.0 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
HERG |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-31.78 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
5.27 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
1778.3 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
4466.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase MLL |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase MLL |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
HL-60 |
GI50 |
15703.63 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
AUC |
3440.64 |
ng.hr.mL-1 |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
Cmax |
3960.0 |
nM |
10.1021/jm2001629 |
| Homo sapiens |
Homo sapiens |
Css |
1.136 |
uM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fabs |
66.0 |
% |
10.1124/dmd.110.034629 |
| Homo sapiens |
Homo sapiens |
IC50 |
500000000000.0 |
nM |
10.1021/jm00118a004 |
| Homo sapiens |
HOP-62 |
GI50 |
29040.23 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
12133.89 |
nM |
None |
| Homo sapiens |
Hs-578T |
GI50 |
31768.74 |
nM |
None |
| Homo sapiens |
HT-29 |
GI50 |
19453.6 |
nM |
None |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
IGROV-1 |
GI50 |
66680.68 |
nM |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
20596.2 |
nM |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
K562 |
GI50 |
24774.22 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Keap1/Nrf2 |
AC50 |
4030.0 |
nM |
None |
| Homo sapiens |
Kelch-like ECH-associated protein 1 |
Max_Activity_Concent |
50.0 |
uM |
None |
| Homo sapiens |
KM12 |
GI50 |
42953.64 |
nM |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
LOX IMVI |
GI50 |
36982.82 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Lysosomal alpha-glucosidase |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
M14 |
GI50 |
55847.02 |
nM |
None |
| Homo sapiens |
Malme-3M |
GI50 |
20464.45 |
nM |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
GI50 |
10000.0 |
nM |
None |
| Homo sapiens |
MDA-MB-231 |
GI50 |
43251.38 |
nM |
None |
| Homo sapiens |
MDA-MB-435 |
GI50 |
69662.65 |
nM |
None |
| Homo sapiens |
MDA-N |
GI50 |
45814.19 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
MES-SA |
Activity |
1.01 |
None |
10.1021/jm0491851 |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
1412.5 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
MOLT-4 |
GI50 |
24378.11 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Mothers against decapentaplegic homolog 3 |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Multidrug and toxin extrusion protein 1 |
IC50 |
26000.0 |
nM |
10.1021/jm2001629 |
| Homo sapiens |
Multidrug and toxin extrusion protein 2 |
IC50 |
74000.0 |
nM |
10.1021/jm2001629 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Activity |
9.0 |
% |
10.1681/asn.v133595 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Activity |
32.0 |
% |
10.1053/jhep.2003.50331 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
2000.0 |
nM |
10.1124/mol.63.5.1094 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
8300.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Multidrug resistance-associated protein 5 |
Activity |
5.9 |
% |
10.1021/jm2014666 |
| Homo sapiens |
Multidrug resistance-associated protein 5 |
IC50 |
30000.0 |
nM |
10.1124/mol.63.5.1094 |
| Homo sapiens |
Multidrug resistance-associated protein 5 |
Inhibition |
95.0 |
% |
10.1021/jm2014666 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
2000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscleblind-like protein 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
21978.6 |
nM |
None |
| Homo sapiens |
NCI-H226 |
GI50 |
48865.24 |
nM |
None |
| Homo sapiens |
NCI-H23 |
GI50 |
65313.06 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
40086.67 |
nM |
None |
| Homo sapiens |
NCI-H460 |
GI50 |
27989.81 |
nM |
None |
| Homo sapiens |
NCI-H522 |
GI50 |
17864.88 |
nM |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide S receptor |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Neuropeptide S receptor |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
18356.4 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
23109.3 |
nM |
None |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
OVCAR-3 |
GI50 |
12387.97 |
nM |
None |
| Homo sapiens |
OVCAR-4 |
GI50 |
59429.22 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
90782.05 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
29174.27 |
nM |
None |
| Homo sapiens |
PC-3 |
GI50 |
33265.96 |
nM |
None |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
26854.5 |
nM |
None |
| Homo sapiens |
Peripheral myelin protein 22 |
Potency |
42561.5 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
22700.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
23700.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
34300.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
Inhibition |
4.7 |
% |
10.1021/ml200293c |
| Homo sapiens |
P-glycoprotein 1 |
% maximum response |
98.2 |
% |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
28.5 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
646.0 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_ATPase activity |
10.8 |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_Papp |
22.7 |
None |
None |
| Homo sapiens |
Phosphodiesterase 1 |
IC50 |
45000.0 |
nM |
10.1021/jm50001a001 |
| Homo sapiens |
Phosphodiesterase 1 |
IC50 |
100000.0 |
nM |
10.1021/jm00076a003 |
| Homo sapiens |
Phosphodiesterase 10A |
Ki |
1000.0 |
nM |
10.1021/jm040217u |
| Homo sapiens |
Phosphodiesterase 11A |
Inhibition |
16.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 11A |
Inhibition |
57.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 11A |
Inhibition |
92.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 11A |
Ki |
400.0 |
nM |
10.1021/jm040217u |
| Homo sapiens |
Phosphodiesterase 2A |
IC50 |
3240.0 |
nM |
10.1021/jm9905054 |
| Homo sapiens |
Phosphodiesterase 2A |
IC50 |
3600.0 |
nM |
10.1021/jm00076a003 |
| Homo sapiens |
Phosphodiesterase 2A |
IC50 |
4000.0 |
nM |
10.1021/jm50001a001 |
| Homo sapiens |
Phosphodiesterase 3 |
IC50 |
43000.0 |
nM |
10.1021/jm50001a001 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4 |
IC50 |
500.0 |
nM |
10.1016/s0960-894x(98)00497-1 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
4500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
520.0 |
nM |
10.1021/jm00076a003 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
574.0 |
nM |
10.1021/jm9905054 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
2831.0 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 6 |
Ki |
125.0 |
nM |
10.1021/jm040217u |
| Homo sapiens |
Phosphodiesterase 7 |
Ki |
600.0 |
nM |
10.1021/jm040217u |
| Homo sapiens |
Phosphodiesterase 7B |
Inhibition |
3.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 7B |
Inhibition |
48.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 7B |
Inhibition |
92.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 8A |
IC50 |
4000.0 |
nM |
10.1016/j.ejmech.2020.113123 |
| Homo sapiens |
Phosphodiesterase 8A |
Inhibition |
13.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 8A |
Inhibition |
55.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Phosphodiesterase 8A |
Inhibition |
88.0 |
% |
10.1016/j.ejmech.2019.04.020 |
| Homo sapiens |
Plasma |
PPB |
90.0 |
% |
10.1021/jm2001629 |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
4.0 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
2238.7 |
nM |
None |
| Homo sapiens |
Prelamin-A/C |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Protein prune homolog |
IC50 |
780.0 |
nM |
10.1016/j.ejmech.2012.08.020 |
| Homo sapiens |
Rap guanine nucleotide exchange factor 3 |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Rap guanine nucleotide exchange factor 3 |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Rap guanine nucleotide exchange factor 4 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Rap guanine nucleotide exchange factor 4 |
Potency |
112201.8 |
nM |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
1191.7 |
nM |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
18887.6 |
nM |
None |
| Homo sapiens |
RPMI-8226 |
GI50 |
10000.0 |
nM |
None |
| Homo sapiens |
Serine-protein kinase ATM |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase PLK1 |
Potency |
11917.3 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SF-268 |
GI50 |
79615.94 |
nM |
None |
| Homo sapiens |
SF-295 |
GI50 |
18967.06 |
nM |
None |
| Homo sapiens |
SF-539 |
GI50 |
31477.48 |
nM |
None |
| Homo sapiens |
SH-SY5Y |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-MEL-2 |
GI50 |
34593.94 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
42953.64 |
nM |
None |
| Homo sapiens |
SK-MEL-5 |
GI50 |
21627.19 |
nM |
None |
| Homo sapiens |
SN12C |
GI50 |
33962.53 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
46881.34 |
nM |
None |
| Homo sapiens |
SNB-75 |
GI50 |
28054.34 |
nM |
None |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
Inhibition |
18.4 |
% |
10.1021/jm00381a019 |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
81000.0 |
nM |
10.1021/jm2001629 |
| Homo sapiens |
Solute carrier family 22 member 2 |
IC50 |
2600.0 |
nM |
10.1021/jm2001629 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
91.9 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
312.58 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
89.24 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
91.8 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
83.1 |
% |
10.1021/jm300212s |
| Homo sapiens |
Sphingomyelin phosphodiesterase |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
SR |
GI50 |
3459.39 |
nM |
None |
| Homo sapiens |
Survival motor neuron protein |
Potency |
891.3 |
nM |
None |
| Homo sapiens |
Survival motor neuron protein |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
SW-620 |
GI50 |
58344.51 |
nM |
None |
| Homo sapiens |
T47D |
GI50 |
35563.13 |
nM |
None |
| Homo sapiens |
TAR DNA-binding protein 43 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Thrombopoietin |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
TK-10 |
GI50 |
17139.57 |
nM |
None |
| Homo sapiens |
Tumor susceptibility gene 101 protein |
Potency |
18337.4 |
nM |
None |
| Homo sapiens |
Tumor susceptibility gene 101 protein |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Tumor susceptibility gene 101 protein |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
316.2 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
2561.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
4554.7 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
14581.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
23715.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
26608.6 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
33498.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
U-251 |
GI50 |
43251.38 |
nM |
None |
| Homo sapiens |
UACC-257 |
GI50 |
39264.49 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 2 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 2 |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 2 |
Potency |
14689.2 |
nM |
None |
| Homo sapiens |
UO-31 |
GI50 |
33036.95 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Human herpesvirus 8 |
ORF 73 |
AC50 |
8866.0 |
nM |
None |
| Influenza A virus |
Nonstructural protein 1 |
Potency |
15848.9 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
2.81 |
% |
10.6019/CHEMBL4513141 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
59450.0 |
nM |
10.6019/CHEMBL3392926 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
62020.0 |
nM |
10.6019/CHEMBL3392926 |
| Mus musculus |
Indoleamine 2,3-dioxygenase 2 |
Inhibition |
55.0 |
% |
10.1016/j.bmcl.2012.10.010 |
| Mus musculus |
L1210 |
IC50 |
340.0 |
nM |
10.1021/jm040772w |
| Mus musculus |
L1210 |
Inhibition |
4.0 |
% |
10.1016/s0960-894x(00)00053-6 |
| Mus musculus |
L1210 |
Inhibition |
4.0 |
% |
10.1021/jm040772w |
| Mus musculus |
L1210 |
Inhibition |
13.0 |
% |
10.1021/jm040772w |
| Mus musculus |
L1210 |
Inhibition |
80.0 |
% |
10.1021/jm040772w |
| Mus musculus |
L1210 |
Inhibition |
89.0 |
% |
10.1016/s0960-894x(00)00053-6 |
| Mus musculus |
L1210 |
Inhibition |
99.0 |
% |
10.1021/jm040772w |
| Mus musculus |
L1210 |
Reduction |
87.0 |
% |
10.1021/jm040772w |
| Mus musculus |
L1210 |
Reduction |
96.0 |
% |
10.1016/s0960-894x(00)00053-6 |
| Mus musculus |
L1210 |
Reduction |
96.0 |
% |
10.1021/jm040772w |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Monoamine oxidase B |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Mus musculus |
ED50 |
72.0 |
mg.kg-1 |
10.1021/jm00118a004 |
| Mus musculus |
Mus musculus |
ED50 |
142.69 |
umol.kg-1 |
10.1021/jm00118a004 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
1412.5 |
nM |
None |
| Oncorhynchus gorbuscha |
Salmon testes DNA |
AC50 |
8587.0 |
nM |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
6956.0 |
nM |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1300.0 |
nM |
10.6019/CHEMBL3392926 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1995.26 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
2511.89 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3162.28 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
3981.07 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7943.28 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
64000.0 |
nM |
10.1021/jm1014617 |
| Plasmodium falciparum |
Plasmodium falciparum |
permeability |
nan |
None |
10.1021/jm1014617 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2078.7 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2133.1 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
2685.5 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
3294.4 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
9285.0 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
10417.9 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
9.85 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
1400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
11220.2 |
nM |
None |
| Rattus norvegicus |
Inositol monophosphatase 1 |
Potency |
28183.8 |
nM |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
15848.9 |
nM |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
10181.5 |
nM |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
17769.3 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
36000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
37300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
38000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
38200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
39000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
276.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
320.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
332.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
369.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
370.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
406.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
35.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
36.5 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
38.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
40.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
42.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
46.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
55.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
56.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
57.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
63.17 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
65.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
71.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
3.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
4.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
4.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
5.2 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
5.5 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
133.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
150.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
156.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
163.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
168.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
98.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
99.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
100.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
100.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
571.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
643.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
703.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
710.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
720.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
756.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
127.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
130.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
136.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
140.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
146.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
229.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
5.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
5.5 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
5.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
6.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.17 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.5 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1486.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1580.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1633.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1636.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1735.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
2070.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
37.08 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
37.2 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
37.62 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
38.13 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
39.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
39.77 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
144700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
148200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
150000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
156000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
157000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
83.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
87.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
87.5 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
88.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
90.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
90.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.0 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.2 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.23 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.48 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.25 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
389000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
393300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
395000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
395300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
399700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
400500.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
57.45 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
58.8 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
58.97 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.45 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.57 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
60.65 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.5 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.5 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
8.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
9.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
10.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
10.83 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
12.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
15.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
95.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
100.8 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
103.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
113.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
116.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
116.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1042830.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1074830.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1166330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1171500.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1245330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1406000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.6 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.03 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.2 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.23 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.27 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
57700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
59700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
63200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
63300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
63500.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
65700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6120000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6250000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6340000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6470000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6750000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6790000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.5 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.67 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.33 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.83 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
10800.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
11180.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
11870.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
12430.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
12470.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
12600.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
31622.8 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
42284.1 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
25929.0 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-1.034 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.178 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.24 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
10.45 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.08583 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
42.3 |
% |
10.1021/ml200293c |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
-23.93 |
% |
10.6019/CHEMBL4513141 |
| Sus scrofa |
Phosphodiesterase 3A |
IC50 |
44000.0 |
nM |
10.1021/jm9905054 |
| Sus scrofa |
Phosphodiesterase 3A |
IC50 |
100000.0 |
nM |
10.1021/jm00076a003 |
| Sus scrofa |
Phosphodiesterase 4A |
IC50 |
5270.0 |
nM |
10.1021/jm9905054 |
| Sus scrofa |
Phosphodiesterase 4A |
IC50 |
6400.0 |
nM |
10.1021/jm00076a003 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
7450.0 |
nM |
10.6019/CHEMBL3392926 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
29330.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
ADMET |
Biotransformation |
nan |
None |
10.1038/s41586-019-1291-3 |
| None |
ADMET |
log10(%HIA +10) |
1.833 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
ADMET |
Papp |
4.2 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
8.9 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
14.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
18.5 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
18.7 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
20.6 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
permeability |
nan |
None |
10.1021/jm1014617 |
| None |
ADMET |
Ratio |
0.005 |
None |
10.1021/jm2001629 |
| None |
ADMET |
Ratio |
0.01 |
None |
10.1021/jm2001629 |
| None |
ADMET |
Ratio |
0.02 |
None |
10.1021/jm2001629 |
| None |
ADMET |
Ratio |
0.1 |
None |
10.1021/jm2001629 |
| None |
ADMET |
Ratio |
0.15 |
None |
10.1021/jm2001629 |
| None |
ADMET |
Ratio |
1.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
1.4 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
2.1 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
3.7 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
6.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
44.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
73.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
75.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
244.0 |
None |
10.1124/dmd.110.034629 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
2.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Activity |
1.472 |
None |
10.1016/j.ejmech.2012.08.020 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
38640.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
IC50 |
59450.0 |
nM |
10.6019/CHEMBL3392926 |
| None |
NON-PROTEIN TARGET |
Inhibition |
nan |
% |
10.1016/j.ejmech.2012.08.020 |
| None |
NON-PROTEIN TARGET |
Potency |
1995.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
2818.4 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
3548.1 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
3981.1 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
6309.6 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
7492.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
7943.3 |
nM |
None |
| None |
No relevant target |
LogD7.4 |
3.97 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Solubility |
3.46 |
ug.mL-1 |
10.1016/j.bmc.2010.08.003 |
| None |
Unchecked |
Ac50 |
5.012 |
uM |
None |
| None |
Unchecked |
Ac50 |
25.12 |
uM |
None |
| None |
Unchecked |
Ac50 |
31.62 |
uM |
None |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
5020.0 |
nM |
None |
| None |
Unchecked |
AC50 |
25118.9 |
nM |
None |
| None |
Unchecked |
AC50 |
31622.8 |
nM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
15.0 |
nM |
10.1021/jm101493z |
| None |
Unchecked |
IC50 |
83.0 |
nM |
None |
| None |
Unchecked |
IC50 |
382.0 |
nM |
None |
| None |
Unchecked |
IC50 |
1579.0 |
nM |
None |
| None |
Unchecked |
IC50 |
3800.0 |
nM |
10.1021/jm2001629 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2013.03.031 |
| None |
Unchecked |
IC50 |
30000.0 |
nM |
10.1016/j.bmc.2013.03.031 |
| None |
Unchecked |
IC50 |
72000.0 |
nM |
10.1021/jm201148s |
| None |
Unchecked |
IC50 |
74500.0 |
nM |
10.1021/jm9905054 |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Imax |
26.0 |
% |
10.1016/j.bmc.2013.03.031 |
| None |
Unchecked |
Imax |
261.0 |
% |
10.1016/j.bmc.2013.03.031 |
| None |
Unchecked |
Inhibition |
50.0 |
% |
10.1021/jm201148s |
| None |
Unchecked |
Inhibition |
78.0 |
% |
10.1021/jm101493z |
| None |
Unchecked |
Inhibition |
90.0 |
% |
10.1021/ml200293c |
| None |
Unchecked |
Inhibition |
96.0 |
% |
10.1021/jm101493z |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2012.08.020 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/jm1014617 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/jm101493z |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Ki |
29.0 |
nM |
None |
| None |
Unchecked |
Ki |
311.0 |
nM |
None |
| None |
Unchecked |
Ki |
9000.0 |
nM |
10.1021/jm040217u |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
10.3 |
nM |
None |
| None |
Unchecked |
Potency |
20.6 |
nM |
None |
| None |
Unchecked |
Potency |
316.2 |
nM |
None |
| None |
Unchecked |
Potency |
3981.1 |
nM |
None |
| None |
Unchecked |
Potency |
4466.8 |
nM |
None |
| None |
Unchecked |
Potency |
5011.9 |
nM |
None |
| None |
Unchecked |
Potency |
6309.6 |
nM |
None |
| None |
Unchecked |
Potency |
7943.3 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Potency |
12589.3 |
nM |
None |
| None |
Unchecked |
Potency |
14125.4 |
nM |
None |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |
| None |
Unchecked |
Potency |
22387.2 |
nM |
None |
| None |
Unchecked |
Potency |
23109.3 |
nM |
None |
| None |
Unchecked |
Potency |
25118.9 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Potency |
35481.3 |
nM |
None |
| None |
Unchecked |
Ratio |
0.137 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
0.303 |
None |
10.1093/toxsci/kft176 |